Related Experiment Video
Updated: Nov 1, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis
Ana Hipólito1,2, Filipa Martins1,2, Cindy Mendes1,2
1CEDOC, Chronic Diseases Research Centre, NOVA Medical School|Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisboa, Portugal.
Metastasis, a major cause of cancer deaths, involves cancer cell spread and secondary tumor formation. This review explores how cancer cell metabolism and signaling pathways drive metastasis, offering new therapeutic targets.
Area of Science:
- Oncology
- Cancer Biology
- Metabolic Pathways
Background:
- Metastasis is the primary cause of cancer mortality, yet its underlying mechanisms remain incompletely understood.
- Cancer cell dissemination, adaptation to foreign microenvironments, and secondary tumor formation are key steps in metastatic disease.
- Metastatic progression is increasingly linked to altered cellular metabolism and reprogrammed signaling pathways.
Purpose of the Study:
- To review the molecular mechanisms coordinating the interplay between metastatic signaling and cellular metabolism.
- To summarize recent findings on metabolic pathways crucial for metastatic cell bioenergetics and biosynthesis.
- To highlight emerging metabolism-based therapeutic strategies for inhibiting metastasis.
Main Methods:
- Literature review of current research on cancer metastasis and cellular metabolism.
- Analysis of molecular mechanisms linking signaling pathways to metabolic reprogramming in metastatic cancer cells.
- Synthesis of findings on key metabolic pathways supporting metastatic phenotypes.
Main Results:
- Metastatic signaling pathways significantly reprogram cellular metabolism to support cancer cell survival and proliferation.
- Specific metabolic pathways, including those involved in bioenergetics and biosynthesis, are critical for metastatic cells.
- Metabolic adaptations enable cancer cells to overcome microenvironmental challenges during dissemination and colonization.
Conclusions:
- Understanding the crosstalk between metastatic signaling and metabolism is crucial for deciphering metastatic disease.
- Targeting metabolic pathways presents a promising therapeutic avenue for combating cancer metastasis.
- Metabolism-based strategies offer potential for developing novel anti-metastatic treatments.
More Related Videos
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment

